Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,393-16,404 of 23,847
Drug study icon
CompletedNCT01142596

Long-term Extension study of Asenapine in Subjects With Schizophrenia (Study P06125)

This study exists to understand how the medication Asenapine holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Asenapine in practice and what may need to be adjusted.

Location not clearly listed
SchizophreniaDrugA study involving a medication or substance.From 20 Years to 64 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Other study type icon
TerminatedEUCTR 2011-004327-13

Safety study of pomaglumetad Methionil in schizophrenia

This study was terminated in Belgium, in Greece, in Germany, .... It is testing pomaglumetad Methionil for schizophrenia.

In Greece
SchizophreniaOther
Countries
Belgium, Greece, Germany, ...
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
Behavioral study icon
WithdrawnNCT06733558

Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Albuquerque
Depression, BipolarityBehavioralFrom 18 Years to 80 Years
Countries
United States
Sponsor
University of New Mexico
Condition
Depression, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.